Olanib 150 Olaparib 150mg Tablets
Composition: Olaparib 150mg Tablets
Manufactured By: Green Apple Pharmaceuticals Private Limited
Marketed by: Green Apple Pharmaceuticals Private Limited
Form: Tablet
Strength: 150mg
Packing: Pack of 30 tablets in a bottle
Country Of Origin: India
Olanib 150 Olaparib 150mg Tablets Description:
Olanib 150 Tablet -Olaparib 150mg is a medication classified as a PARP inhibitor, used primarily in the treatment of certain types of cancers such as ovarian, breast, pancreatic, and prostate cancer.
Uses:
Olanib 150 (Olaparib 150mg) Tablets is prescribed for:
- Treatment of advanced ovarian, breast, pancreatic, or prostate cancers, particularly in patients with BRCA gene mutations.
- Maintenance therapy for patients who have responded to platinum-based chemotherapy.
Side Effects:
Olanib 150 Olaparib 150mg Tablets may cause side effects, which can range from mild to serious.
Common Side Effects:
- Nausea or vomiting
- Fatigue or tiredness
- Loss of appetite
- Headache
- Anemia (low red blood cell count)
- Diarrhea
- Abdominal pain
Serious Side Effects:
- Signs of infection (fever, chills, sore throat)
- Shortness of breath or chest pain
- Severe abdominal pain
- Symptoms of anemia (pale skin, unusual tiredness)
- Unexplained bruising or bleeding
- Allergic reactions (swelling, rash, difficulty breathing)
If any serious side effects occur, seek medical attention promptly.
Dosage:
The usual recommended dose of Olaparib is 300mg (two 150mg tablets) taken orally twice a day, or as directed by a healthcare provider. Dosage may be adjusted based on individual tolerance, side effects, or other medications. Always follow your healthcare provider’s instructions. Taking more than the recommended dose of Olaparib can increase the risk of side effects and may not improve the effectiveness of the medication. Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it.
















